Key Highlights
- $30M Series A funding led by ExSight Ventures and a major corporate investor.
- Funds to advance Horizon’s Polaris platform for first-in-human studies.
- Board appointments of Dr. Firas M. Rahhal and Dr. William A. Link.
- AI-driven Polaris system enhances surgeon capabilities with precision control and augmented visualization.
Source: Business Wire
Notable Quotes
- “Robotic cataract surgery makes a lot of sense. The Horizon system will make surgeons more consistent and faster, with far less complications.” — Dr. Firas M. Rahhal, Founder and General Partner at ExSight Ventures
- “Surgical robotics was a priority area for us when we founded ExSight Ventures. Horizon Robotics defines the inevitable future of ophthalmic surgery.” — Dr. Michael Nissen, Co-Founder at ExSight Ventures
- “Polaris is poised to capitalize on the next era in surgical robotics, enhancing surgeon’s capabilities with precision robotic control.” — Jean-Pierre Hubschman, M.D., Founder and CEO at Horizon Surgical Systems
SoHC's Take
The $30M Series A financing marks a significant milestone for Horizon Surgical Systems, reflecting growing investor confidence in AI-powered medical robotics. The Polaris platform promises to revolutionize ophthalmic surgeries, particularly in cataract procedures, by augmenting a surgeon’s precision and consistency. With Horizon’s leadership bolstered by top-tier industry experts and experienced investors, this advancement signals a promising future for robotics in microsurgery, with the potential to make complex procedures safer, faster, and more accessible.
